Patent Number: 7,087,237

Title: Ocular solutions

Abstract: Containing at least one macrolide antibiotic and/or mycophenolic acid provide anti-inflammatory, anti-cell proliferation, anti-cell migration, anti-angiogenesis, antimicrobial, and antifungal effects. In one embodiment, the solution is administered intraocularly after cataract surgery before insertion of a replacement intraocular lens, resulting in reduced posterior capsular opacification which may eliminate the need for a subsequent surgery. The solution may be one that is invasively administered, for example, an irrigation or volume replacement solution containing at least one macrolide antibiotic such as tacrolimus, sirolimus, everolimus, cyclosporine, and ascomycin, or mycophenolic acid. The solution may be one that is non-invasively or topically administered in the form of drops, ointments, gels, creams, etc. and may include eye lubricants and contact lens solutions.

Inventors: Peyman; Gholam (New Orleans, LA)

Assignee: Advanced Ocular Systems Limited

International Classification: A61K 9/00 (20060101); A61F 13/00 (20060101); A61F 2/00 (20060101)

Expiration Date: 8/08/02018